MBX Net Receivables from 2010 to 2026
| MBX Stock | 32.87 4.17 14.53% |
Net Receivables | First Reported 2010-12-31 | Previous Quarter 784.3 K | Current Value 823.5 K | Quarterly Volatility 244.2 K |
Check MBX Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MBX Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 7.6 M, Interest Income of 7.6 M or Depreciation And Amortization of 167.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.26. MBX financial statements analysis is a perfect complement when working with MBX Biosciences Valuation or Volatility modules.
MBX | Net Receivables | Build AI portfolio with MBX Stock |
Latest MBX Biosciences' Net Receivables Growth Pattern
Below is the plot of the Net Receivables of MBX Biosciences Common over the last few years. It is MBX Biosciences' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MBX Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
MBX Net Receivables Regression Statistics
| Arithmetic Mean | 255,519 | |
| Geometric Mean | 195,295 | |
| Coefficient Of Variation | 95.56 | |
| Mean Deviation | 179,207 | |
| Median | 142,000 | |
| Standard Deviation | 244,169 | |
| Sample Variance | 59.6B | |
| Range | 681.5K | |
| R-Value | 0.69 | |
| Mean Square Error | 33.7B | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | 33,133 | |
| Total Sum of Squares | 953.9B |
MBX Net Receivables History
About MBX Biosciences Financial Statements
MBX Biosciences investors use historical fundamental indicators, such as MBX Biosciences' Net Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MBX Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 784.3 K | 823.5 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Additional Tools for MBX Stock Analysis
When running MBX Biosciences' price analysis, check to measure MBX Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MBX Biosciences is operating at the current time. Most of MBX Biosciences' value examination focuses on studying past and present price action to predict the probability of MBX Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MBX Biosciences' price. Additionally, you may evaluate how the addition of MBX Biosciences to your portfolios can decrease your overall portfolio volatility.